New and emerging renal tumour entities

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F16%3A10322435" target="_blank" >RIV/00216208:11140/16:10322435 - isvavai.cz</a>

Výsledek na webu

<a href="http://www.sciencedirect.com/science/article/pii/S1756231716000062" target="_blank" >http://www.sciencedirect.com/science/article/pii/S1756231716000062</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.mpdhp.2016.01.005" target="_blank" >10.1016/j.mpdhp.2016.01.005</a>

Jazyk výsledku

angličtina

Název v původním jazyce

New and emerging renal tumour entities

Popis výsledku v původním jazyce

In this review, we discuss new and emerging renal cell carcinoma RCC) entities, including anaplastic lymphoma kinase (ALK) RCC, ncocytic variant of chromophobe RCC, atrophic kidney-like renal umour, biphasic alveolosquamoid RCC, tubulocystic RCC, thyroidlike ollicular carcinoma of the kidney, succinate dehydrogenasedeficient CC, BirteHoggeDube syndrome-associated renal tumour, ereditary leiomyomatosis/renal cell carcinoma associated RCC, tuberous clerosis-associated RCC, PTEN hamartoma tumour syndrome, lear cell papillary RCC, acquired cystic disease-associated CC, Xp11.2 RCC, t(6;11) RCC and renal hemangioblastoma. These umours have clinical, pathological and genetic features distinct from her common RCCs and therefore are important to recognize. ome of them have been recognized as distinct histological subtypes n the 2016 World Health Organization Classification. However, further tudies are needed to lucidate their clinicopathologic features and olecular mechanisms.

Název v anglickém jazyce

New and emerging renal tumour entities

Popis výsledku anglicky

In this review, we discuss new and emerging renal cell carcinoma RCC) entities, including anaplastic lymphoma kinase (ALK) RCC, ncocytic variant of chromophobe RCC, atrophic kidney-like renal umour, biphasic alveolosquamoid RCC, tubulocystic RCC, thyroidlike ollicular carcinoma of the kidney, succinate dehydrogenasedeficient CC, BirteHoggeDube syndrome-associated renal tumour, ereditary leiomyomatosis/renal cell carcinoma associated RCC, tuberous clerosis-associated RCC, PTEN hamartoma tumour syndrome, lear cell papillary RCC, acquired cystic disease-associated CC, Xp11.2 RCC, t(6;11) RCC and renal hemangioblastoma. These umours have clinical, pathological and genetic features distinct from her common RCCs and therefore are important to recognize. ome of them have been recognized as distinct histological subtypes n the 2016 World Health Organization Classification. However, further tudies are needed to lucidate their clinicopathologic features and olecular mechanisms.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FP - Ostatní lékařské obory

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2016

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Diagnostic Histopathology

ISSN

1756-2317

e-ISSN

—

Svazek periodika

22

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

10

Strana od-do

47-56

Kód UT WoS článku

—

EID výsledku v databázi Scopus

2-s2.0-84957921810